The ScientistChemyx: Targeting Tissues with CRISPR Editing and Stereotaxic TechniquesThe ScientistCRISPR/Cas9 genome editing technology has introduced valuable versatility in the design of pre-clinical animal models for functional genomics research. Ac… Continue reading
Stem cell: Arthritic knee research in $33 million awardCapitol WeeklyThe California stem cell agency has awarded $33 million for clinical trial research, but not before some governing board members questioned the appropriateness of backing an effort to… Continue reading
Stanford Medical Center Report |
Stanford receives grant to create center for support of cancer immunotherapy
Stanford Medical Center Report Together, the centers will form a network of laboratories to support adult and pediatric immunotherapy trials by analyzing patients’ immune phenotype and function and performing deep tumor profiling. The grant provides the Stanford center approximately … |
Stanford Medical Center Report |
Stanford receives grant to create center for support of cancer immunotherapy
Stanford Medical Center Report Together, the centers will form a network of laboratories to support adult and pediatric immunotherapy trials by analyzing patients’ immune phenotype and function and performing deep tumor profiling. The grant provides the Stanford center approximately … |
STAT |
Gene Therapy May Fight Brain Cancer’s Return
WebMD FRIDAY, Oct. 27, 2017 (HealthDay News) — A new form of gene therapy shows promise in battling recurrent brain cancer. The phase 1 clinical trial included 56 patients with recurrent high-grade glioma brain cancer. Three years after the gene therapy … Tocagen’s new gene therapy offers a flicker of hope for aggressive brain cancerSTAT Safety of gene therapy for brain tumours tested in early trialCancer Research UK Gene therapy shows promise against brain cancer in early testingPhilly.com Xconomy –Markets Insider all 7 news articles » |
STAT |
Gene Therapy May Fight Brain Cancer’s Return
WebMD FRIDAY, Oct. 27, 2017 (HealthDay News) — A new form of gene therapy shows promise in battling recurrent brain cancer. The phase 1 clinical trial included 56 patients with recurrent high-grade glioma brain cancer. Three years after the gene therapy … Tocagen’s new gene therapy offers a flicker of hope for aggressive brain cancerSTAT Safety of gene therapy for brain tumours tested in early trialCancer Research UK Gene therapy shows promise against brain cancer in early testingPhilly.com Xconomy –Markets Insider all 7 news articles » |